GlassScriptPhysician profile
Herschel B Patel
NPI 1588154975
$814.59
in general payments reported to CMS, 2019-2025
12 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.86 · 2023: $45.49 · 2024: $138 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $800.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $171.02 | 2025 | Inspire |
| Integra Lifesciences Corporation | $137.84 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $117.22 | 2025 | Keytruda |
| Stryker Corporation | $114.63 | 2025 | Na |
| Agiliti Surgical, INC. | $76.66 | 2025 | Lumenis Acupulse Co2 Laser, Boston Scientific Acupulse Duo Co2 Laser |
| Kls-Martin L.P. | $50.08 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $47.53 | 2025 | |
| Ethicon US, LLC | $26.62 | 2025 | Harmonic, Vistaseal |
| Csl Behring | $26.42 | 2023 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $19.07 | 2023 | |
| Pfizer INC. | $13.86 | 2021 | |
| Acera Surgical, INC. | $13.64 | 2025 | Restrata Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herschel Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.